Alcon AG | ALC - Cost Of Sales

Stock Price
67.06
Daily Change
0.30 0.45%
Monthly
8.51%
Yearly
-19.59%
Q1 Forecast
62.72

Alcon AG reported $1.16B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
AstraZeneca USD 3.27B 471M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Philips EUR 2.81B 417M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
Sonova Holding CHF 539.4M 11.5M Dec/2025
UCB EUR 901M 50M Dec/2024